Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers

BACKGROUND: Modified 5-fluorouracil/leucovorin/irinotecan (mFOLFIRI) is a commonly used combination second-line chemotherapeutic regimen in advanced gastric cancer (AGC). MATERIALS AND METHODS: Patients diagnosed with AGC, receiving biweekly mFOLFIRI between July 2013 and June 2016, as second-line c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaswamy, Anant, Ostwal, Vikas, Gupta, Kushal, Simha, Vijai, Toshniwal, Anup, Shetty, Nitin, Nashikkar, Chaitali, Mandavkar, Sarika, Gupta, Sudeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
ORIGINAL ARTICLE: GI Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190392/
https://www.ncbi.nlm.nih.gov/pubmed/30430086
http://dx.doi.org/10.4103/sajc.sajc_232_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190392/
https://www.ncbi.nlm.nih.gov/pubmed/30430086
http://dx.doi.org/10.4103/sajc.sajc_232_17

Ejemplares similares